An NF-κB p65-cIAP2 link is necessary for mediating resistance to TNF-α induced cell death in gliomas

Journal of Neuro-Oncology

Volumn 102, Issue 3, 2011, Pages 367-381

  Zhao, Xueyan ^a   Laver, Travis ^a   Hong, Suk W ^a   Twitty Jr , George B ^a   DeVos, Annelies ^a   DeVos, Marijke ^a   Benveniste, Etty N ^a   Nozell, Susan E ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Cell death; cIAP2; Gliomas; NF B; TNF

Indexed keywords

INHIBITOR OF APOPTOSIS PROTEIN 1; INHIBITOR OF APOPTOSIS PROTEIN 2; PROTEIN BCL 2; PROTEIN BCL XL; RECEPTOR INTERACTING PROTEIN 140; SHORT HAIRPIN RNA; SURVIVIN; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER RESISTANCE; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE OVEREXPRESSION; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UBIQUITINATION;

BRAIN NEOPLASMS; CASPASES; CELL DEATH; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; TIME FACTORS; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79958189859     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-010-0346-y     Document Type: Article

References (64)

1. Naugler WE, Karin M (2008) NF-κB and cancer-identifying targets and mechanisms. Curr Opin Genet Dev 18:19-26
2. Meffert MK, Baltimore D (2005) Physiological functions for brain NF-κB. Trends Neurosci 28:37-43
3. Widera D, Kaus A, Kaltschmidt C, Kaltschmidt B (2008) Neural stem cells, inflammation and NF-κB: basic principle of maintenance and repair or origin of brain tumours? J Cell Mol Med 12:459-470
4. Widera D, Mikenberg I, Kaltschmidt B, Kaltschmidt C (2006) Potential role of NF-κB in adult neural stem cells: the underrated steersman? Int J Dev Neurosci 24:91-102 (Pubitemid 43294615)
5. Gilmore T (2008) www.NF-κB.org
6. Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, Stegh A, Hahn WC, Ligon KL, Louis DN, Brennan C, Chin L, DePinho RA, Cavenee WK (2007) Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 21:2683-2710 (Pubitemid 350070717)
7. Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN, Cavenee WK, DePinho RA (2001) Malignant glioma: genetics and biology of a grave matter. Genes Dev 15:1311-1333 (Pubitemid 32524640)
8. Reifenberger G, Collins VP (2004) Pathology and molecular genetics of astrocytic gliomas. J Mol Med 82:656-670 (Pubitemid 39468490)
9. van den Bent MJ (2006) Adjuvant treatment of high grade gliomas. Ann Oncol 17(Suppl 10):x186-x190
10. Schiff D (2007) Temozolomide and radiation in low-grade and anaplastic gliomas: temoradiation. Cancer Invest 25:776-784
11. Garkavtsev I, Kozin SV, Chernova O, Xu L, Winkler F, Brown E, Barnett GH, Jain RK (2004) The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis. Nature 428:328-332 (Pubitemid 38418804)
12. Nozell S, Laver T, Moseley D, Nowoslawski L, De Vos M, Atkinson GP, Harrison K, Nabors LB, Benveniste EN (2008) The ING4 tumor suppressor attenuates NF-κB activity at the promoters of target genes. Mol Cell Biol 28:6632-6645
13. Wang H, Zhang W, Huang HJ, Liao WS, Fuller GN (2004) Analysis of the activation status of Akt, NFκB, and Stat3 in human diffuse gliomas. Lab Invest 84:941-951
14. Angileri FF, Aguennouz M, Conti A, La Torre D, Cardali S, Crupi R, Tomasello C, Germano A, Vita G, Tomasello F (2008) NF-κB activation and differential expression of survivin and Bcl-2 in human grade 2-4 astrocytomas. Cancer 112:2258-2266 (Pubitemid 351628637)
15. Korkolopoulou P, Levidou G, Saetta AA, El-Habr E, Eftichiadis C, Demenagas P, Thymara I, Xiromeritis K, Boviatsis E, Thomas- Tsagli E, Panayotidis I, Patsouris E (2008) Expression of nuclear factor-κB in human astrocytomas: relation to pI kappa Bα, vascular endothelial growth factor, Cox-2, microvascular characteristics, and survival. Hum Pathol 39:1143-1152
16. Robe PA, Bentires-Alj M, Bonif M, Rogister B, Deprez M, Haddada H, Khac MT, Jolois O, Erkmen K, Merville MP, Black PM, Bours V (2004) In vitro and in vivo activity of the nuclear factor-κB inhibitor sulfasalazine in human glioblastomas. Clin Cancer Res 10:5595-5603
17. Otsuka G, Nagaya T, Saito K, Mizuno M, Yoshida J, Seo H (1999) Inhibition of NF-κB activation confers sensitivity to tumor necrosis factor-alpha by impairment of cell cycle progression in human glioma cells. Cancer Res 59:4446-4452 (Pubitemid 29418767)
18. Moriuchi S, Glorioso JC, Maruno M, Izumoto S, Wolfe D, Huang S, Cohen JB, Yoshimine T (2005) Combination gene therapy for glioblastoma involving herpes simplex virus vector-mediated codelivery of mutant IκBα and HSV thymidine kinase. Cancer Gene Ther 12:487-496 (Pubitemid 40629339)
19. Weaver KD, Yeyeodu S, Cusack JC Jr, Baldwin AS Jr, EwendMG (2003) Potentiation of chemotherapeutic agents following antagonism of NF-κB in human gliomas. J Neurooncol 61:187-196
20. Dhandapani KM, Mahesh VB, Brann DW (2007) Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NF-κB transcription factors. J Neurochem 102:522-538 (Pubitemid 47000605)
21. Yamini B, Yu X, Dolan ME, Wu MH, Kufe DW, Weichselbaum RR (2007) Inhibition of NF-κB activity by temozolomide involves O6-methylguanine induced inhibition of p65 DNA binding. Cancer Res 67:6889-6898 (Pubitemid 47105536)
22. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS Jr (1998) NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281:1680-1683
23. Chu ZL, McKinsey TA, Liu L, Gentry JJ, Malim MH, Ballard DW (1997) Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-κB control. Proc Natl Acad Sci USA 94:10057-10062 (Pubitemid 27406993)
24. Varfolomeev E, Vucic D (2008) (Un)expected roles of c-IAPs in apoptotic and NFκB signaling pathways. Cell Cycle 7:1511-1521 (Pubitemid 351881313)
25. Cao L, Wang Z, Yang X, Xie L, Yu L (2008) The evolution of BIR domain and its containing proteins. FEBS Lett 582:3817-3822
26. Eckelman BP, Salvesen GS (2006) The human anti-apoptotic proteins cIAP1 and cIAP2 bind but do not inhibit caspases. J Biol Chem 281:3254-3260 (Pubitemid 43845937)
27. Shiozaki EN, Chai J, Rigotti DJ, Riedl SJ, Li P, Srinivasula SM, Alnemri ES, Fairman R, Shi Y (2003) Mechanism of XIAP-mediated inhibition of caspase-9. Mol Cell 11:519-527 (Pubitemid 36293842)
28. Srinivasula SM, Hegde R, Saleh A, Datta P, Shiozaki E, Chai J, Lee RA, Robbins PD, Fernandes-Alnemri T, Shi Y, Alnemri ES (2001) A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis. Nature 410:112-116 (Pubitemid 32225846)
29. Bertrand MJ, Milutinovic S, Dickson KM, Ho WC, Boudreault A, Durkin J, Gillard JW, Jaquith JB, Morris SJ, Barker PA (2008) cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol Cell 30:689-700 (Pubitemid 351818251)
30. Declercq W, Vanden Berghe T, Vandenabeele P (2009) RIP kinases at the crossroads of cell death and survival. Cell 138:229-232
31. Varfolomeev E, Goncharov T, Fedorova AV, Dynek JN, Zobel K, Deshayes K, Fairbrother WJ, Vucic D (2008) c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor alpha (TNFalpha)- induced NF-κB activation. J Biol Chem 283:24295-24299
32. Choi C, Kutsch O, Park J, Zhou T, Seol DW, Benveniste EN (2002) Tumor necrosis factor-related apoptosis-inducing ligand induces caspase-dependent interleukin-8 expression and apoptosis in human astroglioma cells. Mol Cell Biol 22:724-736 (Pubitemid 34053053)
33. Nozell S, Laver T, Patel K, Benveniste EN (2006) Mechanism of IFN-beta-mediated inhibition of IL-8 gene expression in astroglioma cells. J Immunol 177:822-830 (Pubitemid 44036582)
34. Ma Z, Qin H, Benveniste EN (2001) Transcriptional suppression of matrix metalloproteinase-9 gene expression by IFN-gamma and IFN-beta: critical role of STAT-1alpha. J Immunol 167:5150-5159 (Pubitemid 33009751)
35. Nozell S, Chen X (2002) p21B, a variant of p21(Waf1/Cip1), is induced by the p53 family. Oncogene 21:1285-1294 (Pubitemid 34185245)
36. Nozell S, Wu Y, McNaughton K, Liu G, Willis A, Paik JC, Chen X (2003) Characterization of p73 functional domains necessary for transactivation and growth suppression. Oncogene 22:4333-4347 (Pubitemid 36897964)
37. Hayden MS, Ghosh S (2008) Shared principles in NF-κB signaling. Cell 132:344-362
38. Catz SD, Johnson JL (2001) Transcriptional regulation of bcl-2 by nuclear factor κB and its significance in prostate cancer. Oncogene 20:7342-7351 (Pubitemid 33078205)
39. Chen C, Edelstein LC, Gelinas C (2000) The Rel/NF-κB family directly activates expression of the apoptosis inhibitor Bcl-x(L). Mol Cell Biol 20:2687-2695 (Pubitemid 30183487)
40. Chen F, Demers LM, Vallyathan V, Lu Y, Castranova V, Shi X (1999) Involvement of 5′-flanking κB-like sites within bcl-x gene in silica-induced Bcl-x expression. J Biol Chem 274:35591-35595 (Pubitemid 129512856)
41. Tracey L, Perez-Rosado A, Artiga MJ, Camacho FI, Rodriguez A, Martinez N, Ruiz-Ballesteros E, Mollejo M, Martinez B, Cuadros M, Garcia JF, Lawler M, Piris MA (2005) Expression of the NF-κB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively. J Pathol 206:123-134 (Pubitemid 40754015)
42. Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, Barrette T, Pandey A, Chinnaiyan AM (2004) ONCOMINE: a cancer microarray database and integrated datamining platform. Neoplasia 6:1-6 (Pubitemid 38391943)
43. Rhodes DR, Kalyana-Sundaram S, Mahavisno V, Varambally R, Yu J, Briggs BB, Barrette TR, Anstet MJ, Kincead-Beal C, Kulkarni P, Varambally S, Ghosh D, Chinnaiyan AM (2007) Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia 9:166-180
44. Loveland BE, Johns TG, Mackay IR, Vaillant F, Wang ZX, Hertzog PJ (1992) Validation of the MTT dye assay for enumeration of cells in proliferative and antiproliferative assays. Biochem Int 27:501-510
45. Lin WW, Karin M (2007) A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 117:1175-1183
46. Li X, Cai L, Chen H, Zhang Q, Zhang S, Wang Y, Dong Y, Cheng H, Qi J (2009) Inhibitor of growth 4 induces growth suppression and apoptosis in glioma U87MG. Pathobiology 76:181-192
47. McCoy MK, Tansey MG (2008) TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease. J Neuroinflammation 5:45.13-45.41
48. Hayashi S, Yamamoto M, Ueno Y, Ikeda K, Ohshima K, Soma G, Fukushima T (2001) Expression of nuclear factor-κB, tumor necrosis factor receptor type 1, and c-Myc in human astrocytomas. Neurol Med Chir (Tokyo) 41:187-195 (Pubitemid 32416972)
49. Kargiotis O, Rao JS, Kyritsis AP (2006) Mechanisms of angiogenesis in gliomas. J Neurooncol 78:281-293 (Pubitemid 44018823)
50. Moore PA, Belvedere O, Orr A, Pieri K, LaFleur DW, Feng P, Soppet D, Charters M, Gentz R, Parmelee D, Li Y, Galperina O, Giri J, Roschke V, Nardelli B, Carrell J, Sosnovtseva S, Greenfield W, Ruben SM, Olsen HS, Fikes J, Hilbert DM (1999) BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science 285:260-263 (Pubitemid 29330000)
51. Sudheerkumar P, Shiras A, Das G, Jagtap JC, Prasad V, Shastry P (2008) Independent activation of Akt and NF-κB pathways and their role in resistance to TNF-alpha mediated cytotoxicity in gliomas. Mol Carcinog 47:126-136 (Pubitemid 351231441)
52. Wilson J, Balkwill F (2002) The role of cytokines in the epithelial cancer microenvironment. Semin Cancer Biol 12:113-120 (Pubitemid 34680740)
53. Atkinson GP, Nozell SE, Harrison DK, Stonecypher MS, Chen D, Benveniste EN (2009) The prolyl isomerase Pin1 regulates the NF-κB signaling pathway and interleukin-8 expression in glioblastoma. Oncogene 28:3735-3745
54. Bao L, Kimzey A, Sauter G, Sowadski JM, Lu KP, Wang DG (2004) Prevalent overexpression of prolyl isomerase Pin1 in human cancers. Am J Pathol 164:1727-1737 (Pubitemid 38529775)
55. Atkinson GP, Nozell SE, Benveniste ET (2010) NF-κB and STAT3 signaling in glioma: targets for future therapies. Expert Rev Neurother 10:575-586
56. Li L, Thomas RM, Suzuki H, De Brabander JK, Wang X, Harran PG (2004) A small molecule Smac mimic potentiates TRAIL-and TNF-α-mediated cell death. Science 305:1471-1474 (Pubitemid 39167668)
57. Li L, Gondi CS, Dinh DH, Olivero WC, Gujrati M, Rao JS (2007) Transfection with anti-p65 intrabody suppresses invasion and angiogenesis in glioma cells by blocking NF-κB transcriptional activity. Clin Cancer Res 13:2178-2190 (Pubitemid 46649888)
58. Tsuboi Y, Kurimoto M, Nagai S, Hayakawa Y, Kamiyama H, Hayashi N, Kitajima I, Endo S (2009) Induction of autophagic cell death and radiosensitization by the pharmacological inhibition of nuclear factor-κB activation in human glioma cell lines. J Neurosurg 110:594-604
59. Kuwayama K, Matsuzaki K, Mizobuchi Y, Mure H, Kitazato KT, Kageji T, Nakao M, Nagahiro S (2009) Promyelocytic leukemia protein induces apoptosis due to caspase-8 activation via the repression of NFκB activation in glioblastoma. Neuro Oncol 11:132-141
60. Zheng M, Morgan-Lappe SE, Yang J, Bockbrader KM, Pamarthy D, Thomas D, Fesik SW, Sun Y (2008) Growth inhibition and radiosensitization of glioblastoma and lung cancer cells by small interfering RNA silencing of tumor necrosis factor receptor-associated factor 2. Cancer Res 68:7570-7578
61. Sharma V, Tewari R, Sk UH, Joseph C, Sen E (2008) Ebselen sensitizes glioblastoma cells to Tumor Necrosis Factor (TNFalpha)- induced apoptosis through two distinct pathways involving NF-κB downregulation and Fas-mediated formation of death inducing signaling complex. Int J Cancer 123:2204-2212
62. Jiang W, Cazacu S, Xiang C, Zenklusen JC, Fine HA, Berens M, Armstrong B, Brodie C, Mikkelsen T (2008) FK506 binding protein mediates glioma cell growth and sensitivity to rapamycin treatment by regulating NF-κB signaling pathway. Neoplasia 10:235-243 (Pubitemid 351337518)
63. Ichiyama T, Nishikawa M, Lipton JM, Matsubara T, Takashi H, Furukawa S (2001) Thiopental inhibits NF-κB activation in human glioma cells and experimental brain inflammation. Brain Res 911:56-61 (Pubitemid 32728238)
64. LaCasse EC, Mahoney DJ, Cheung HH, Plenchette S, Baird S, Korneluk RG (2008) IAP-targeted therapies for cancer. Oncogene 27:6252-6275